Tamoxifen, an anti-estrogen widely used for breast cancer treatment, h
as variable agonistic effects on the uterus (mostly concerning endomet
rium but also myometrium). 14 cases of growing uterine fibroleiomyomas
during tamoxifen treatment which required hysterectomy are described.
No myometrial malignancy was observed. (C) 1998 Elsevier Science Ltd.
AU rights reserved.